Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peptide epitope-imprinted polymer microarrays for selective protein recognition. Application for SARS-CoV-2 RBD protein. | Chem Sci | 2022 | 35222909 | PubTator, text mining | PubMed |
| NAD+ in COVID-19 and viral infections. | Trends Immunol | 2022 | 35221228 | PubTator, text mining | PubMed |
| Viroporins: Structure, function, and their role in the life cycle of SARS-CoV-2. | Int J Biochem Cell Biol | 2022 | 35219876 | PubTator, text mining | PubMed |
| A global survey in the developmental landscape of possible vaccination strategies for COVID-19. | Clin Immunol | 2022 | 35218966 | PubTator, text mining | PubMed |
| Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department. | Diagn Microbiol Infect Dis | 2022 | 35216863 | PubTator, text mining | PubMed |
| Adaptive Evolution as a Driving Force of the Emergence and Re-Emergence of Mosquito-Borne Viral Diseases. | Viruses | 2022 | 35216028 | PubTator, text mining | PubMed |
| Targeting Viral Methyltransferases: An Approach to Antiviral Treatment for ssRNA Viruses. | Viruses | 2022 | 35215972 | PubTator, text mining | PubMed |
| Secondary Structure of Subgenomic RNA M of SARS-CoV-2. | Viruses | 2022 | 35215915 | PubTator, text mining | PubMed |
| Clinical Tick-Borne Encephalitis in a Roe Deer (Capreolus capreolus L.). | Viruses | 2022 | 35215891 | PubTator, text mining | PubMed |
| SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System. | Viruses | 2022 | 35215794 | PubTator, text mining | PubMed |
| The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2. | Pathogens | 2022 | 35215181 | PubTator, text mining | PubMed |
A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland-First Results. | Vaccines (Basel) | 2022 | 35214772 | PubTator, text mining | PubMed |
| A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protects Pigs against PCV2b Challenge and Induces Serum Neutralizing Antibody Response against CSFV. | Vaccines (Basel) | 2022 | 35214763 | PubTator, text mining | PubMed |
| Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination. | Vaccines (Basel) | 2022 | 35214735 | PubTator, text mining | PubMed |
| Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance. | Mol Cell Biochem | 2022 | 35211823 | PubTator, text mining | PubMed |
| Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic. | Anal Bioanal Chem | 2022 | 35211785 | PubTator, text mining | PubMed |
| Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials. | BMJ Open | 2022 | 35210336 | PubTator, text mining | PubMed |
| Digital Microfluidic qPCR Cartridge for SARS-CoV-2 Detection. | Micromachines (Basel) | 2022 | 35208320 | PubTator, text mining | PubMed |
Analysis of the Efficacy of Universal Screening of Coronavirus Disease with Antigen-Detecting Rapid Diagnostic Tests at Point-or-Care Settings and Sharing the Experience of Admission Protocol-A Pilot Study. | J Pers Med | 2022 | 35207807 | PubTator, text mining | PubMed |
| Structures and Dynamics of Dengue Virus Nonstructural Membrane Proteins. | Membranes (Basel) | 2022 | 35207152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=61